Key result
Diabetes mellitus was not associated with an increased risk of 2-year all-cause mortality in patients undergoing transcatheter aortic valve replacement.
Why the study?
Does diabetes mellitus impact all-cause mortality and peri-procedural complications in patients with severe aortic stenosis undergoing TAVR?
Cohort (n=443)
No
Does diabetes mellitus impact all-cause mortality and peri-procedural complications in patients with severe aortic stenosis undergoing TAVR?
Answers are grounded in this paper and cite their sources.
Supports equivalent TAVR mortality risk regardless of diabetes; leaves open effects on complications and longer-term outcomes.
BACKGROUND: Diabetes mellitus (DM) and aortic stenosis (AS) are frequent findings in the elderly population. Data regarding the influence of DM on the outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) due to AS are limited. The aim of this study was to examine the impact of DM on TAVR outcomes. METHODS: We investigated 443 patients with severe AS undergoing TAVR. Subjects were divided into insulin-dependent diabetic mellitus (IDDM) patients (N = 44), non-dependent insulin diabetic mellitus (NIDDM) patients (N = 114) and non-diabetics (N = 285) of whom 31 (74%), 86 (79%) and 209 (76%) respectively had trans-femoral TAVR. Peri-procedural complications and outcomes were recorded according to the Valve Academic Research Consortium-2 criteria. RESULTS: Patients with IDDM as well as NIDDM demonstrated similar complication rates compared with non-diabetic patients, except for acute kidney injury (AKI) grade 3 [4 (2%) and 3 (3%) vs. 1 (0.4%) respectively, p = 0.032]. Kaplan-Meier survival analysis showed that DM, regardless of the type of treatment, was not associated with increased 2 years mortality (Log-rank p value 0.44). Multivariate cox regression analysis adjusted for age, gender, coronary artery disease, DM, AKI3, hypertension, chronic renal failure and peripheral vascular disease found that AKI3 was associated with increased risk of 2 years mortality [HR = 7.35, 95% CI 2.16-25.07, p = 0.001] whereas female gender was found as a protective factor [HR = 0.47, 95% CI 0.28-0.8, p = 0.005], and DM was not associated with increased risk. CONCLUSIONS: Following TAVR, DM patients seem to have similar peri-procedural and mid-term outcomes compared with patients without DM, while IDDM patients seem to suffer greater incidence of AKI. Further research in larger cohorts of patients is needed to validate our results.
No takes yet. Share an insight, caveat, or question.
Berkovitch et al. (2015) conducted a cohort in Severe aortic stenosis (n=443). Diabetes mellitus vs. Non-diabetic patients was evaluated on All-cause mortality at 2 years (HR 0.83, 95% CI 0.49-1.40, p=0.48). Diabetes mellitus was not associated with an increased risk of 2-year all-cause mortality in patients undergoing transcatheter aortic valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: